Jim Simons Myovant Sciences Ltd. Transaction History

Renaissance Technologies LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$24.03 - $27.02 $867,483 - $975,422	36,100 Added 12.51%	324,600 $8.75 Million
Q3 2022 Nov 14, 2022	BUY	$11.6 - $20.44 $112,520 - $198,268	9,700 Added 3.48%	288,500 $5.18 Million
Q2 2022 Aug 12, 2022	BUY	$7.78 - $14.69 $448,128 - $846,144	57,600 Added 26.04%	278,800 $3.47 Million
Q1 2022 May 13, 2022	BUY	$11.38 - $16.4 $745,390 - $1.07 Million	65,500 Added 42.07%	221,200 $2.95 Million
Q4 2021 Feb 11, 2022	SELL	$14.31 - $23.87 $1.3 Million - $2.17 Million	-90,900 Reduced 36.86%	155,700 $2.42 Million
Q3 2021 Nov 12, 2021	BUY	$18.94 - $26.99 $371,299 - $529,111	19,604 Added 8.64%	246,600 $5.53 Million
Q2 2021 Aug 13, 2021	BUY	$17.07 - $24.56 $3.87 Million - $5.58 Million	226,996 New	226,996 $5.17 Million
Q1 2021 May 13, 2021	SELL	$20.46 - $25.18 $2.29 Million - $2.81 Million	-111,700 Closed	0 $0
Q4 2020 Feb 10, 2021	SELL	$13.8 - $27.62 $1.37 Million - $2.74 Million	-99,200 Reduced 47.04%	111,700 $3.09 Million
Q3 2020 Nov 13, 2020	SELL	$14.05 - $22.6 $5.04 Million - $8.1 Million	-358,366 Reduced 62.95%	210,900 $2.96 Million
Q2 2020 Aug 13, 2020	BUY	$7.34 - $20.84 $3.97 Million - $11.3 Million	540,566 Added 1883.51%	569,266 $11.7 Million
Q1 2020 May 14, 2020	BUY	$6.55 - $14.76 $187,985 - $423,612	28,700 New	28,700 $217,000
Q3 2019 Nov 13, 2019	SELL	$5.19 - $9.46 $105,357 - $192,038	-20,300 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$8.69 - $25.0 $176,407 - $507,500	20,300 New	20,300 $184,000

61.3K

Ticker MYOV
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 96,802,800
Description
Myovant Sciences Ltd., a biopharmaceutical company, develops redefine care for women and for men. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.